Current Affairs - Science - Discussion

India has achieved a groundbreaking milestone by initiating its first-in-human gene therapy trial for Haemophilia, marking a significant advancement in its healthcare and biotechnology sectors. The trial is being conducted by BRIC-inStem in collaboration with CMC Vellore and represents a pioneering move toward personalized and precision medicine in the country. This effort highlights India's growing capability in translating scientific research into clinical applications. With rapid expansion in the biotech industry, bolstered by initiatives like the BIO-E3 Policy, India is not only addressing critical health challenges but also reinforcing biotechnology as a pillar of economic growth and national development.